NeoPlasia

Published by: Elsevier Science Inc.  

Groups

  1. GSK Faculty (11)
  2. Molecular Pharmacology and Chemistry Program Faculty (11)
  3. Sloan Kettering Institute Faculty (11)
  4. Department of Medicine (7)
  5. Radiology, Department of (7)
  6. Center for Hematologic Malignancies (6)
  7. Hematologic Malignancies Research (6)
  8. Hematologic Malignancies, Division of (6)
  9. Molecular Imaging and Therapy Service (6)
  10. Sloan Kettering Institute Postdocs (4)
Search Within

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.

NeoPlasia – authorized name for:

Name ISSN / ISBN Publisher
Neoplasia 15228002 Neoplasia Press, Inc
Neoplasia 15228002 Elsevier Inc.
Neoplasia 1522-8002 Elsevier Science, Inc.
Neoplasia 1522-8002 Neoplasia Press, Inc
Neoplasia 1522-8002 Nature America, Inc
Neoplasia 15228002 Unknown
NeoPlasia 1522-8002 Elsevier Science, Inc.
Neoplasia 1522-8002 Neoplasia Press, Inc
NeoPlasia 1522-8002 Elsevier Science Inc.
Neoplasia 1522-8002 Unknown
Neoplasia 15228002 Neoplasia Press, Inc
Neoplasia 1522-8002 Elsevier Science, Inc.
Neoplasia 1476-5586 Elsevier Science, Inc.
Neoplasia 1522-8002 Elsevier Science, Inc.
Neoplasia 15228002 The Authors
NeoPlasia 1522-8002 2024
Neoplasia (New York) 1522-8002 Unknown
Neoplasia (New York) 1476-5586 Elsevier Inc.
Neoplasia (New York, N.Y.) 14765586 Elsevier Inc.
Neoplasia (United States) 14765586 Unknown
Neoplasia (United States) 15228002 2016
Neoplasia (United States) 15228002 2022
Neoplasia (United States) 15228002 The Authors.
Neoplasia (United States) 15228002 Neoplasia Press, Inc
Neoplasia (United States) 1522-8002 Elsevier Science, Inc.
Neoplasia (United States) 1522-8002 Elsevier Science, Inc.
Neoplasia (United States) 15228002 2025
Neoplasia (United States) 15228002 2024
Neoplasia (United States) 15228002 The Authors
Neoplasia (United States) 15228002 2018